Accès libre

Antimicrobial resistance and virulence factor gene profiles of Enterococcus spp. isolated from giant panda oral cavities

À propos de cet article

Citez

Introduction

Enterococcus spp. are natural bacteria in the gut of both humans and animals. As an opportunistic pathogen, it can cause infection when animal immunity is low. The Enterococcus genus presently contains over 50 species, among which E. faecalis and E. faecium dominate, accounting for more than 80% of isolates. In addition, Enterococcus spp. have become the second most common iatrogenic infection causing bacteria after Staphylococcus aureus. E. faecalis is of great importance as a leading opportunistic pathogen causing nosocomial infections, the frequent types of which include endocarditis, meningitis, and urinary tract, wound, and neonatal infections (2).

While Enterococcus spp. are not regarded as normal inhabitants of the oral cavity, they have been isolated from samples from patients with various oral conditions including carious lesions, periodontitis, root canal infection (38) and peri-implantitis (15). Some researchers believe that the pathogenic mechanism of Enterococcus spp. in the oral cavity may be related to the ability to form recalcitrant biofilms in the root canal (28) and carry virulence factors. The most studied virulence-associated determinants are aggregation substances, surface adhesins, sex pheromones, lipoteichoic acid, production of extracellular superoxide, gelatinase, hyaluronidase, and the cytolysin toxin (21). In addition, E. faecalis from the oral cavity not only causes pulp disease, but also has the ability to colonise other tissue and infect it systemically, e.g. in the form of endocarditis (25).

Due to their ubiquity in human and animal faeces and persistence in the environment, Enterococcus spp. are considered indicators of faecal contamination in water. Moreover, Enterococcus spp. serve as important key indicator bacteria for human and veterinary resistance surveillance systems. Antimicrobial-resistant Enterococcus spp. have the potential to cause zoonotic diseases, being possessed of intrinsic resistance to various antimicrobial agents including aminoglycosides and cephalosporins, and able to acquire resistance genes from other bacteria by conjugation via plasmids or transposons and bacteriophages (11). This phenomenon has led to an increase in the prevalence rate of multidrug resistant (MDR) Enterococcus spp.

Information on the antimicrobial susceptibility characteristics of Enterococcus spp. isolates from the giant panda oral cavity is scarce. Only a small amount of metagenome analysis has been done on the bacterial composition of this microbiome. The first aim of the present study was to take this analysis further, focusing on selected resistance genes as well as additional relevant phenotypic resistance to assess whether the isolated strains could represent a reservoir for antimicrobial resistance traits. The second aim was to evaluate the major virulence traits of Enterococcus spp. isolates.

Material and Methods

Bacterial strains. A total of 108 strains comprising 54 of E. faecalis and 54 of E. faecium were used for the study and were isolated from sublingual saliva samples of 15 giant pandas. They were collected from captive giant pandas living in the Chengdu Research Base of Giant Panda Breeding in the Sichuan Province, China. All isolates were presumptively identified by phenotypic methods, including Gram staining and Enterococcus spp. chromogenic medium (Hopebiol Biotech, Qingdao, China) growth. We used 16 S rDNA sequences for final identification and the confirmed isolates were stored in Luria Bertani broth containing 50% glycerol at −20°C for further analyses.

Antimicrobial susceptibility test. Susceptibility to 10 antimicrobial agents (penicillin (10 U), ampicillin (10 μg), ciprofloxacin (5 μg), levofloxacin (5μg), erythromycin (15 μg), gentamicin (120 μg), streptomycin (300 μg), tetracycline (30 μg), linezolid (30 μg), and vancomycin (30 μg)) was assessed using the disk diffusion method according to the criteria of the Clinical and Laboratory Standards Institute (6). Drug-sensitive paper was purchased from Hangzhou Microbial Reagent Co. (Hangzhou, China) and Thermo Fisher Scientific (Waltham, MA, USA). Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 25923 strains were used for quality control. Isolates resistant to at least one member of three different antimicrobial groups were considered MDR (9).

DNA extraction and screening for antibiotic resistance genes. Total genomic DNA was extracted from isolates using the TIANamp Bacteria DNA kit (Tiangen Biotech, Beijing, China) according to the manufacturer’s instructions. DNA samples were stored at −20°C.

Seventeen antimicrobial resistance genes were detected using PCR. The primers used in this study are shown in Table 1. All the design sequences utilised in this research were found through GenBank, and then Oligo7 was used to design the primers. To amplify the aac(6')/aph(2″), aph(3')-Ⅲ , ant(6)-I, ant(4')-Ia, tetL, vanA, vanB, blaTEM, cfr, optrA and blaZ genes a single PCR was used. The PCR program and amplification system in part exploit prior knowledge in the literature referenced in Table 1. For detecting the presence of the tetA, tetC, tetM, ermA, ermB, and ermC genes, a multiplex PCR was used according to protocols described previously (3).

Primers used for PCR detection of antimicrobial resistance genes

Resistance to Resistance gene Primer sequence (5’→3’) Amplicon (bp) References
Aminoglycoside aac(6')/aph(2″) CCAAGAGCAATAAGGGCATA CACTATCATAACCACTACCG 220 this study
aph(3')-Ⅲ GCCGATGTGGATTGCGAAAA GCTTGATCCCCAGTAAGTCA 292 this study
ant(6)-I ACTGGCTTAATCAATTTGGG GCCTTTCCGCCACCTCACCG 597 (21)
ant(4')-Ia CTTGGACGCTGAGATATATGAGCACC GGAAAGTTGACCAGACATTACGAACT 294 (10)
Tetracycline tetM GAGGTCCGTCTGAACTTTGCG AGAAAGGATTTGGCGGCACT 900 (21)
tetA GGCACCGAATGCGTATGAT AAGCGAGCGGGTTGAGAG 480 (21)
tetC CTGGGCTGCTTCCTAATGC AGCTGTCCCTGATGGTCGT 580 (21)
tetL TGGTCCTATCTTCTACTCATTC TTCCGATTTCGGCAGTAC 385 (14)
Vancomycin vanA GGGAAAACGACAATTGC GTACAATGCGGCCGTTA 732 (14)
vanB CAAAGCTCCGCAGCTTGCATG TGCATCCAAGCACCCGATATAC 484 (14)
β-lactams blaZ ACTTCAACACCTGCTGCTTTC TAGGTTCAGATTGGCCCTTAG 240 (34)
blaTEM CCAATGCTTAATCAGTGAGG ATGAGTATTCAACATTTCCG 858 (23)
Erythromycin ermA TCTAAAAAGCATGTAAAAGAAA CGATACTTTTTGTAGTCCTTC 553 this study
ermB CCGTTTACGAAATTGGAACAGGTAAAGGGC GAATCGAGACTTGAGTGTGC 359 this study
ermC GCTAATATTGTTTAAATCGTCAATTCC GGATCAGGAAAAGGACATTTTAC 460 this study
Linezolid cfr TGAAGTATAAAGCAGGTTGGGAGTCA ACCATATAATTGACCACAAGCAGC 746 (32)
optrA AGGTGGTCAGCGAACTAA ATCAACTGTTCCCATTCA 1395 (5)

The PCR products were separated by gel electrophoresis in a 1.0% agarose gel stained with GoldView (Sangon Biotech, Shanghai, China), visualised under ultraviolet light, and photographed using a gel documentation system (Bio-Rad, Hercules, CA, USA).

Detection of virulence-associated determinants. Bacterial DNA extract was thawed immediately before performing PCR. Genes encoding the asa1, gelE, cylA, esp, hyl, ace, and efaA enterococcal virulence factors were detected using PCR under conditions described previously (20, 26, 35). All primers are shown in Table 2.

Primers for different virulence genes

Virulence factor Genes Primer sequence (5ʹ→3ʹ) PCR product size (bp) References
Aggregation substance asa1 GCACGCTATTACGAACTATGA TAAGAAAGAACATCACCACGA 375 (4)
Gelatinase gelE TATGACAATGCTTTTTGGGAT AGATGCACCCGAAATAATATA 213 (4)
Cytolysin cylA ACTCGGGGATTGATAGGC GCTGCTAAAGCTGCGCTT 688 (4)
Enterococcal surface protein esp AGATTTCATCTTTGATTCTTGG AATTGATTCTTTAGCATCTGG 510 (4
Hyaluronidase hyl ACAGAAGAGCTGCAGGAAATG GACTGACGTCCAAGTTTCCAA 276 (4)
Accessory colonization factor ace GAATTGAGCAAAAGTTCAATCG GTCTGTCTTTTCACTTGTTTC 1108 (21)
Endocarditis antigen efaA GCCAATTGGGACAGACCCTC CGCCTTCTGTTCCTTCTTTGGC 688 (21)
Results

Antimicrobial susceptibility. The results of the resistance of Enterococcus strains to selected antimicrobials are given in Fig.1. The 108 isolates from the saliva of giant pandas from Chengdu showed different degrees of resistance to 10 antimicrobials.

Fig. 1

Resistance rates of 54 E. faecalis and 54 E. faecium strains to 10 antibiotics

P – penicillin; GM120 – gentamicin (120μg); E – erythromycin; VA – vancomycin; LZD – linezolid; CIP – ciprofloxacin;S300 – streptomycin (300μg); AM – ampicillin; TE – tetracycline; LEV – levofloxacin

The drug resistance rates of the 54 Enterococcus faecalis strains were 61.1% to penicillin, 48.1% to gentamicin, 90.7% to erythromycin, 55.6% to vancomycin, 100% to linezolid, 98.1% to ciprofloxacin, 33.3% to streptomycin, 55.6% to ampicillin, 83.3% to tetracycline, and 94.4% to levofloxacin. For the 54 E. faecium isolates, the resistance rates of 90.7% to penicillin, 100.0% to erythromycin, 88.9% to ampicillin, 98.1% to tetracycline, and 98.1% to levofloxacin were higher than those of the E. faecalis isolates.

It is worth noting that all 108 Enterococcus spp. isolates were resistant to three or more classes of antimicrobials. Among the E. faecalis strains, 34 (62.96%) isolates were resistant to six different antimicrobial agents, whereas among E. faecium strains only 25 (46.3%) isolates were found to be resistant to the same number of antimicrobials.

Antibiotic resistance genes. The results of investigation of the presence of resistance genes are summarised in Fig. 2. The detection rates of the tetL and tetK genes in E. faecalis isolates were 20.37% and 24.07%, respectively. However, tetL and tetC were detected in all E. faecium isolates. The tetM gene was not present in any strain of either bacterium.

Fig. 3

Presence of E. faecalis and E. faecium resistance genes

tetL, tetC, tetM, and tetA – tetracycline resistance genes; ermA, ermB, and ermC – erythromycin resistance genes; blaZ and blaTEM – β-lactam resistance genes; vanA and vanB – vancomycin resistance genes; ant6-Ⅰ, ant3'-Ⅲ, aac6'-aph2'', and ant(4')-Ia – aminoglycoside resistance genes; cfr and optrA – linezolid resistance genes

The ermA gene was detected in all 54 E. faecium isolates and in 12.96% of those of E. faecalis. In contrast, the detection rates of the ermB and ermC genes in the E. faecium isolates were very low at 3.7% and 1.85%, respectively. In E. faecalis isolates, the detection rate of the ermB gene was 5.56%, while ermC was not detected. The β-lactam resistance gene was in very low presence, with a detection rate of only 1.85% in E. faecium isolates.

Among E. faecalis isolates, the vanA gene was found in 50 strains (92.59%), whereas the vanB gene was not detected. In E. faecium isolates, the detection rate of the vanA gene decreased to 46.3%, while the vanB gene was likewise not detected. For aminoglycoside drugs, we selected four common resistance genes; namely, ant6-I, ant3'-III, aac6'-aph2'', and ant(4')-Ia. Among the E. faecalis isolates, only the aac6'-aph2'' gene was found, and it was identified in 3 strains (5.56%). The detection rates of the aminoglycosides resistance genes in E. faecium were 3.7% for ant6-I, 14.81% for ant3'-I, 5.56% for aac6'-aph2'', and 64.81% for ant(4')-Ia.

Finally, it is noteworthy that the drug resistance rates of isolates to linezolid were very high in antimicrobial susceptibility test. Both the genes conferring resistance, cfr and optrA, were detected in PCR. However, the detection rate of cfr gene in E. faecium isolates was as high as 90.74%, but no cfr gene was detected in those of E. faecalis. The opposite was true for the optrA gene, which was detected at a rate of only 3.7% in E. faecium isolates, but at a very high rate of 96.30% in those of E. faecalis.

Virulence-associated determinants. The results of investigation of the presence of virulence-associated determinants are summarised in Fig. 3.

Fig. 3

Presence of E. faecalis and E. faecium virulence-associated determinants

ace – collagen‐binding protein; asa1 – aggregation substance; cylA – cytolysin; efa-A – endocarditis antigen;

esp – enterococcal surface protein; gelE – gelatinase; hyl – hyaluronidase

We tested for the presence of seven virulence factors. The cylA, esp and hyl genes were not detected. All 54 E. faecalis strains yielded the efaA, gelE, asal, and ace genes in abundance, with respective 98.1%, 98.1%, 92.6% and 87.0% detection rates. The same phenomenon was also observed in the 54 E. faecium strains, but the detection rates for these four genes were lower. The most common type of virulence factor carrier was efaA-gelE-asal-ace among both E. faecalis and E. faecium (Tables 3 and 4).

Virulence-associated gene profile of E. faecalis isolates from giant panda saliva samples

Virulence-associated gene Number of isolates Proportion
efaA-gelE 2 3.70%
gelE-asal 1 1.85%
efaA-ace 1 1.85%
efaA-gelE-ace 1 1.85%
efaA-gelE-asa1 4 7.41%
efaA-gelE-asal-ace 45 83.33%

Virulence-associated gene profile of E. faecium isolates from giant panda saliva samples

Virulence-associated gene Number of isolates Proportion
efaA-ace 1 1.85%
gelE-asal 2 3.70%
efaA-gelE-asal-ace 45 83.33%
None 6 11.11%
Discussion

In view of the universal finding of MDR in all the isolates tested and the 34 out of 54 (62.96%) E. faecalis and 25 out of 54 (46.30%) E. faecium strains found to be resistant to six to seven antibiotics, high rates of drug resistance exist in Enterococcus spp. colonising captive giant panda oral cavities, and indicate a severe problem.

Since the 1990s, Enterococcus spp. have emerged as leading nosocomial pathogens and been shown to have the ability to acquire and spread resistance genes readily (38). However, the role of Enterococcus spp. such as E. faecalis that inhabit the oral cavity as a potential reservoir for resistance has not been clarified yet. The emergence of Enterococcus isolates that have multidrug resistance phenotypes, which confer resistance to three or more unrelated families of antibiotics, is considered a serious problem. Increasing resistance to antimicrobials of which tetracycline, rifampicin, ciprofloxacin, and erythromycin are some examples has been reported in E. faecalis (1). The results of this study showed that 98% of the E. faecalis strains and 98% of the E. faecium strains were resistant to ciprofloxacin, which is much higher than the 25% resistance rate reported in India (31) and 38.1% in Portugal (18). Previous studies have suggested that the rampant use of fluoroquinolones has contributed to the emergence of high-level or complete resistance and a high prevalence of MDR (13). Such observations have also been reported in previous studies of human cases of enterococcal urinary tract infections (16). The resistance rate to levofloxacin at 94.4% was like the rate to ciprofloxacin. Erythromycin, tetracycline and linezolid were found to be resisted by the bacteria in this study as much as quinolones. In our study, 90.7% of E. faecalis isolates and 100% of E. faecium isolates were resistant to erythromycin. This result is similar to that of Sattari-Maraji et al. (30), for whom the resistance rate to erythromycin was close to 100%. The ermA gene had the highest detection rates of the erythromycin resistance genes, being present in 12.96% and 100% respectively of E. faecalis and E. faecium isolates. Only low inclusions of ermB and ermC were detected, which was inconsistent with the high detection rate of ermB reported by Guerrero-Ramos et al. (10) and Bin et al. (14) in meat products.

The resistance rates of E. faecalis and E. faecium isolates to tetracycline were as high as 83.3% and 98.1%. The common tetracycline resistance genes tetL, tetC, tetA and tetM were selected for detection. The rate at which tetL and tetC were detected was high, but the tetM carriage rate was 0%. This is inconsistent with the high detection rates of these genes in isolated strains observed in hospitals by Tian et al. (33).

The optrA gene, which confers transferable resistance to oxazolidinones (linezolid and tedizolid) and phenicols (chloramphenicol and florfenicol), has been detected in E. faecalis and E. faecium isolates of both human and animal origin. This gene encodes an ABC transporter and has been detected more frequently in E. faecalis than in E. faecium isolates. The cfr gene also confers the same resistance; it encodes an rRNA methyltransferase that modifies the adenine residue at position 2503 in domain V of the 23S rRNA. Besides resistance to oxazolidinones and phenicols, it also confers resistance to lincosamides, pleuromutilins, and streptogramin A (23). The spread of these genes could significantly limit treatment options for MDR bacteria infections (33). In our experiments, the resistance of E. faecalis and E. faecium to linezolid was also very high, reaching 100% and 83%. The detection rates of optrA and cfr were extreme opposites in the two enterococcal species, with detection rates of 0% and 96.3% in E. faecalis and 90.74% and 3.7% in E. faecium. The detection of these genes in E. faecalis was similar to that of Chen et al. (5) in a linezolid-resistant strain. However, in most reports, Enterococcus spp. are still susceptible to linezolid (4, 9, 37).

Enterococci have different resistance strengths to different types of β-lactam antibiotics (16). In our study, antimicrobial susceptibility tests to penicillin and ampicillin were carried out, and demonstrated prevalence rates of E. faecalis and E. faecium resistant to ampicillin of 55.6% and 88.9%, respectively and rates for the isolates resistant to penicillin of 61.1% and 90.7%. Enterococcus faecalis isolates were more susceptible to β-lactams than E. faecium isolates, but susceptibility to aminoglycosides was higher in E. faecium isolates than E. faecalis isolates. The drug resistance rates of E. faecalis to gentamicin and streptomycin were 48.2% and 33.3% and those of E. faecium were 24.1% and 27.8%.

For vancomycin resistance, we observed significant differences in the susceptibility of E. faecalis and E. faecium, with resistance rates of 55.6% and 16.6%, respectively. The two genotypes vanA and vanB are the most frequent among vancomycin-resistant strains. The detection rates of E. faecalis and E. faecium with the vanA gene were 92.59% and 46.3%, respectively, while isolates with vanB were not detected, which was inconsistent with the resistance rate to vancomycins. Ribeiro et al. (29) reported that even when the vanA gene was detected, there was no resistance to vancomycin. In an investigation of oral dental diseases, oral isolates of E. faecalis were sensitive to vancomycin, which was a favourable finding (27). At the same time, we observed that the isolates were resistant to antibiotics that were no longer used; the possible explanation might be the incorporation of resistance genes into the host chromosome or the physical linkage of the antibiotic genes on the plasmid.

The presence of virulence-associated determinants and antibiotic-resistant phenotypes may enhance the pathogenesis of the Enterococcus strains due to increased adhesion, colonisation, extracellular production of enzymes, and evasion of the host immune response.

E. faecalis isolates harboured significantly more virulence-associated determinants than E. faecium isolates in previously reported data (36). In our experiment, only four virulence-associated determinants were detected; namely, the efaA, gelE, asa1, and ace genes, but the detection rate for them was above 85% and higher in E. faecalis than in E. faecium. The virulence-associated determinants carried by 83.33% (90/108) of the isolates were of efaA-gelE-asa1-ace type. In our study, gelE was extensively present in both E. faecalis and E. faecium isolates (98.1% and 87.0%, respectively), similarly to the results of Landete et al. (17) (81% and 60%, respectively).

Genes for enterococcal surface protein and cell wall adhesins (espfm, espfs, efaAfm, and efaAfs) were as frequent in their corresponding species as they were found to be by Togay et al. (34). In our study, efaA was found in 98.1% of E. faecalis and 85.2% of E. faecium strains, but the esp gene was not detected. This phenomenon is a contrary finding to that of Creti et al. (7) and Martin et al. (19), who both discovered a high incidence of these genes in Enterococcus spp. isolates. In this study, up to 98.1% of E. faecalis isolates were gelE-positive and 92.6% were asa1-positive, which is consistent with previous studies and provides further evidence that these virulence-associated determinants are widely distributed among E. faecalis strains (24). Interestingly, the hyl and cylA gene detection rates were 0%, making results similar to those of Creti et al. (7) but consistent with other previous studies (22). An 87% proportion of E. faecalis isolates and 85.2% of E. faecium isolates were ace-positive.

In summary, our data illustrate that giant panda saliva presents a reservoir of Enterococcus spp. strains with multi-drug resistance and these isolates carry some virulence-associated determinants that may increase the risk of disease. Consequently, continued monitoring of Enterococcus spp. for antibiotic resistance and virulence-associated determinants should be performed in giant pandas’ oral cavities that will help to establish strategies for prevention and surveillance of greater virulence and resistance in these bacteria as pathogens for this endangered species.

eISSN:
2450-8608
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Life Sciences, Molecular Biology, Microbiology and Virology, other, Medicine, Veterinary Medicine